May 23, 2022 — A specific protein in blood vessel cells plays a major role in the development of vascular and cardiovascular diseases: The presence of too many "thromboxane A2 receptors" hinders the formation of new blood vessels. A research team led by the Martin Luther University Halle-Wittenberg (MLU) was able to describe the underlying process for the first time.

May 23, 2022 — New data from a study of more than 100 million hospitalizations using machine learning augmentation was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. The findings reveal percutaneous coronary intervention (PCI) is safe and increasing among cancer patients.

May 23, 2022 — Insights from a National Inpatient Sample Database examining race and the rates of cardiac catheterization or revascularization for acute coronary syndrome (ACS) patients with a history of cocaine use is being presented to

May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income residents hospitalized with ST-elevation myocardial infarction (STEMI) when compared to higher-income residents. The findings were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions. 

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during the chronic maintenance period.

May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented as late-breaking clinical research at the Society

Subscribe Now